ZNF521 and ovarian carcinoma: In exosomes derived from Bone Marrow Stromal Cells (BMSCs), ZNF521 was identified as hub protein and associated with poor outcome in gastric and ovarian cancers [18] where OCSC are shown to be implicated in the progression of ovarian carcinoma and resistance to therapy [14–16].